plasma-neurofilament

Newest first, then by address. Each study has a usefulness score out of 100 (rubric version 4.0); tap a score to see what makes it up. Tags were assigned automatically from each study's title and summary. The same studies as a filter in the library.

1. 72/100

   Impact of amyloid and cardiometabolic risk factors on prognostic capacity of plasma neurofilament light chain for neurodegeneration

   ✓ Peer-reviewed alzhub usefulness score 72 out of 100. Alzheimer's research & therapy · 2024-09-12 · Biomarkers

   This study suggests that the prognostic capacity of plasma NfL may be amplified in individuals with Aβ or hypertension.

   • Biomarkers
   • Risk Factors
2. 45/100

   The impact of kidney function on plasma neurofilament light and phospho-tau 181 in a community-based cohort: the Shanghai Aging Study

   ✓ Peer-reviewed alzhub usefulness score 45 out of 100. Alzheimer's research & therapy · 2024-02-12 · Biomarkers

   Considering renal function and age is crucial when interpreting AD biomarkers in the general aging population.

   • Biomarkers
3. 52/100

   Plasma neurofilament light chain as a biomarker of Alzheimer's disease in Subjective Cognitive Decline and Mild Cognitive Impairment

   ✓ Peer-reviewed alzhub usefulness score 52 out of 100. Journal of neurology · 2022-03-14 · Biomarkers

   Plasma NfL levels might be a promising biomarker for neurodegeneration to discriminate cognitive decline due to AD from other conditions causing cognitive impairment in prodromal stages.

   • Biomarkers
   • Early Stage
4. 52/100

   The reliability and validity of DSM 5 diagnostic criteria for neurocognitive disorder and relationship with plasma neurofilament light in a down syndrome population

   ✓ Peer-reviewed alzhub usefulness score 52 out of 100. Scientific reports · 2021-06-29 · Biomarkers

   The validity of dementia diagnostic criteria depends on their ability to distinguish dementia symptoms from pre-existing cognitive impairments.

   • Biomarkers
   • Diagnosis
   • Down Syndrome
5. 38/100

   Plasma Neurofilament Light and Alzheimer's Disease Biomarkers in Down Syndrome: Results from the Down Syndrome Biomarker Initiative (DSBI)

   ✓ Peer-reviewed alzhub usefulness score 38 out of 100. Journal of Alzheimer's disease : JAD · 2019-01-01 · Biomarkers

   Plasma NF-L is associated with progressive neurodegeneration as well as with declines in cognitive and functional measures in adults with DS.

   • Biomarkers
   • Down Syndrome

All topic tags with their study counts